300529 健帆生物
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)24.59712.98725.66138.82235.370
总资产报酬率 ROA (%)14.2177.96517.39729.82130.649
投入资产回报率 ROIC (%)16.0328.87119.29733.56130.706

边际利润分析
销售毛利率 (%)81.31280.02582.33584.97285.239
营业利润率 (%)44.83228.28941.32052.99854.048
息税前利润/营业总收入 (%)44.52425.34040.09752.13251.507
净利润/营业总收入 (%)35.92622.14635.35944.69744.751

收益指标分析
经营活动净收益/利润总额(%)95.70596.29392.58395.40596.232
价值变动净收益/利润总额(%)2.6220.0001.0342.0411.472
营业外收支净额/利润总额(%)-3.116-4.376-1.244-0.761-2.171

偿债能力分析
流动比率 (X)3.7713.9934.5927.9116.005
速动比率 (X)3.4133.5294.1057.4025.640
资产负债率 (%)41.12043.12333.71329.65511.909
带息债务/全部投入资本 (%)30.62432.35523.88318.524--
股东权益/带息债务 (%)216.684197.769304.068421.911-11,339.709
股东权益/负债合计 (%)143.018131.670195.735235.469732.728
利息保障倍数 (X)42.508-14.371-56.060-112.140-37.000

营运能力分析
应收账款周转天数 (天)10.29127.77035.46029.3670.000
存货周转天数 (天)229.497344.136223.177142.0150.000